Transgenomic's Discovery Services Team Supports Study Linking Stem Cell Mutation to Blood Disorder and Development of Leukemia: Targeted Mutation Sc

Source: Transgenomic, Inc. via PR Newswire
Date: April 18, 2006

OMAHA, Neb., April 18 /PRNewswire-FirstCall/ -- Transgenomic, Inc. announced today the publication of a study in which contributed to the finding that patients with a disorder called polycythemia vera (PV) have a mutation in a gene in blood-forming stem cells. These stem cells represent an early developmental stage in which the blood cells have not yet committed to a specialized function. The genetic mutation is likely to be associated with the excessive production of red blood cells in the bone marrow which is characteristic of PV.

Commentary: This study may have implications for using stem cells to treat blood diseases and disorders.